Eyebiotech Limited is a startup, most recent round Acquired.
Eyebiotech Limited is a startup. Eyebiotech Limited has been acquired.
Eyebiotech Limited is a clinical-stage ophthalmology biotechnology company developing a next-generation pipeline of therapies for back-of-the-eye diseases. The company was acquired by Merck in 2024.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.